{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:carotid:recurrent-stenosis",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-08T20:48:00.000Z",
    "updated": "2026-01-08T20:48:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "review_status": "pending_review",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/carotid",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "topic_id": "CAROTID-011"
  },
  "content": {
    "title": "Recurrent Carotid Stenosis",
    "definition": {
      "primary": "Hemodynamically significant stenosis (\u226550%) occurring at the site of prior carotid intervention (endarterectomy or stenting), caused by neointimal hyperplasia (early recurrence) or progression of atherosclerosis (late recurrence).",
      "key_concepts": [
        "Early recurrence (< 2 years) typically due to myointimal hyperplasia",
        "Late recurrence (> 2 years) usually represents new atherosclerosis",
        "Incidence 5-10% after CEA, 5-15% after CAS",
        "Management differs from de novo carotid stenosis"
      ]
    },
    "pathophysiology": {
      "early_recurrence": {
        "timeframe": "< 24 months post-intervention",
        "mechanism": "Myointimal (neointimal) hyperplasia",
        "histology": "Smooth muscle cell proliferation with extracellular matrix deposition",
        "characteristics": [
          "Smooth, homogeneous lesion",
          "Less prone to embolization than atherosclerotic plaque",
          "May stabilize or regress over time",
          "Often asymptomatic"
        ]
      },
      "late_recurrence": {
        "timeframe": "> 24 months post-intervention",
        "mechanism": "Recurrent atherosclerosis",
        "histology": "Typical atherosclerotic plaque with lipid core, necrosis, inflammation",
        "characteristics": [
          "Similar embolic potential to primary atherosclerosis",
          "Progressive if untreated",
          "Associated with ongoing risk factors"
        ]
      }
    },
    "epidemiology": {
      "post_cea": {
        "incidence": "5-22% depending on definition and follow-up duration",
        "symptomatic_recurrence": "1-4%",
        "risk_factors": [
          "Primary closure (vs patch)",
          "Female sex",
          "Continued smoking",
          "Diabetes",
          "Hyperlipidemia",
          "Prior radiation"
        ]
      },
      "post_cas": {
        "incidence": "5-15%",
        "in_stent_restenosis": "More common than post-CEA recurrence in some series",
        "risk_factors": [
          "Diabetes",
          "Small reference vessel diameter",
          "Long lesion length",
          "Residual stenosis"
        ]
      }
    },
    "clinical_presentation": {
      "asymptomatic": "Majority (> 80%) detected on surveillance imaging",
      "symptomatic": {
        "presentations": [
          "TIA (hemispheric or retinal)",
          "Stroke",
          "Amaurosis fugax"
        ],
        "considerations": [
          "Myointimal hyperplasia less likely to cause symptoms than atherosclerotic recurrence",
          "Symptoms mandate more aggressive management"
        ]
      }
    },
    "diagnosis": {
      "surveillance_protocol": {
        "post_cea": [
          "Duplex at 1 month, 6 months, then annually for 5 years",
          "Beyond 5 years: individualized based on findings"
        ],
        "post_cas": [
          "Duplex at 1 month, 6 months, then annually",
          "Stent visualization may be challenging"
        ]
      },
      "imaging": [
        {
          "modality": "Duplex ultrasound",
          "utility": "Primary surveillance tool, may be affected by stent artifact",
          "criteria": "PSV > 125-150 cm/s suggests \u2265 50% stenosis (may need stent-specific criteria)"
        },
        {
          "modality": "CT angiography",
          "utility": "Confirmatory, excellent for stent evaluation",
          "limitations": "Beam hardening artifact from stent"
        },
        {
          "modality": "MR angiography",
          "utility": "Alternative when CT contraindicated, no stent artifact with TOF technique",
          "limitations": "May overestimate stenosis"
        },
        {
          "modality": "Conventional angiography",
          "utility": "Gold standard, reserved for equivocal cases or planned intervention"
        }
      ]
    },
    "management": {
      "medical_optimization": {
        "all_patients": [
          "Antiplatelet therapy (aspirin minimum)",
          "High-intensity statin therapy",
          "Blood pressure control (< 130/80)",
          "Smoking cessation",
          "Diabetes management (HbA1c < 7%)"
        ]
      },
      "asymptomatic_recurrence": {
        "approach": "Generally conservative unless very high-grade (> 80%)",
        "rationale": "Lower stroke risk than de novo stenosis, especially with myointimal hyperplasia",
        "surveillance": "More frequent duplex (every 6 months)"
      },
      "symptomatic_recurrence": {
        "indication": "\u2265 50% stenosis with ipsilateral symptoms",
        "treatment_options": [
          {
            "option": "Carotid artery stenting",
            "preferred_when": "Post-CEA recurrence (hostile neck, scar tissue)",
            "outcomes": "Technical success > 95%, perioperative stroke 2-4%"
          },
          {
            "option": "Redo carotid endarterectomy",
            "preferred_when": "Post-CAS recurrence, symptomatic in-stent restenosis",
            "challenges": "Scarring, cranial nerve injury risk, may require patch angioplasty"
          },
          {
            "option": "Carotid artery bypass",
            "preferred_when": "Failed prior interventions, extensive scarring",
            "technique": "Interposition bypass with saphenous vein"
          }
        ]
      },
      "post_cas_in_stent_restenosis": {
        "options": [
          {
            "technique": "Balloon angioplasty alone",
            "applicability": "First-line for focal restenosis"
          },
          {
            "technique": "Drug-coated balloon",
            "applicability": "May reduce re-restenosis rates"
          },
          {
            "technique": "Additional stent placement",
            "applicability": "Recoil or flow-limiting dissection"
          },
          {
            "technique": "Surgical endarterectomy with stent removal",
            "applicability": "Recurrent or complex in-stent restenosis"
          }
        ]
      }
    },
    "outcomes": {
      "stroke_risk": {
        "asymptomatic_recurrence": "1-2% annual stroke risk (lower than primary stenosis)",
        "symptomatic_recurrence": "Higher risk, similar to symptomatic primary stenosis"
      },
      "intervention_outcomes": {
        "repeat_intervention": "Higher complication rates than primary procedures",
        "reintervention_restenosis": "20-30% may develop further recurrence"
      }
    },
    "prevention": {
      "surgical_technique": [
        "Patch closure reduces early recurrence vs primary closure",
        "Eversion endarterectomy may have lower recurrence than conventional"
      ],
      "stenting_technique": [
        "Adequate post-dilation",
        "Avoid underexpanded stent"
      ],
      "medical": [
        "Aggressive statin therapy",
        "Blood pressure control",
        "Smoking cessation"
      ]
    },
    "statement": "Recurrent Carotid Stenosis is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Carotid that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Recurrent Carotid Stenosis helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Recurrent Carotid Stenosis include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Recurrent Carotid Stenosis."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "relationships": {
    "requires": [
      "vascular:procedures:carotid-endarterectomy",
      "vascular:procedures:carotid-stenting"
    ],
    "enables": [
      "vascular:procedures:redo-cea",
      "vascular:procedures:carotid-stenting-restenosis"
    ],
    "related_to": [
      "vascular:carotid:stenosis",
      "vascular:pathophysiology:neointimal-hyperplasia"
    ],
    "skos:broader": [
      "http://dbpedia.org/resource/Knowledge"
    ],
    "skos:related": [
      "http://dbpedia.org/resource/Concept"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Recurrent_Carotid_Stenosis"
    ]
  },
  "educational": {
    "learning_objectives": [
      "Differentiate early (myointimal) from late (atherosclerotic) recurrence",
      "Apply appropriate surveillance protocols post-CEA and post-CAS",
      "Determine indications for reintervention",
      "Select optimal treatment strategy based on prior intervention and anatomy",
      "Understand prevention strategies"
    ],
    "key_points": [
      "Early recurrence is usually myointimal hyperplasia, late is atherosclerosis",
      "Myointimal hyperplasia has lower embolic potential than atherosclerosis",
      "Patch closure at CEA reduces recurrence compared to primary closure",
      "CAS is preferred for post-CEA recurrence (avoids hostile neck)",
      "Asymptomatic recurrence often managed conservatively"
    ],
    "clinical_pearls": [
      "Duplex velocity criteria may differ for stented vs non-stented arteries",
      "Consider CAS for post-CEA recurrence to avoid scarred surgical field",
      "Surgical stent removal may be needed for recurrent in-stent restenosis",
      "Aggressive medical therapy reduces late atherosclerotic recurrence"
    ]
  },
  "references": {
    "evidence_basis": "Retrospective studies, meta-analyses",
    "key_guidelines": [
      {
        "organization": "SVS/ESVS",
        "topic": "Management of carotid disease",
        "year": 2022
      }
    ],
    "terminology": {
      "snomed_ct": "233962006",
      "icd10": "I65.2"
    }
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). Recurrent Carotid Stenosis. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Recurrent_Carotid_Stenosis",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}